DNMT3B antibody (N-Term)
Quick Overview for DNMT3B antibody (N-Term) (ABIN7464502)
Target
See all DNMT3B AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Cross-Reactivity
- Human, Rat
-
Purification
- Purified by antigen-affinity chromatography.
-
Immunogen
- Recombinant protein encompassing a sequence within the N-terminus region of human DNMT3B. The exact sequence is proprietary.
-
Isotype
- IgG
-
-
-
-
Application Notes
- WB: 1:1000-1:10000. ICC/IF: 1:100-1:1000. IHC-P: 1:100-1:1000. IP: 1:100-1:500. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Comment
-
Positive Control: HeLa nuclear , GFP-tagged DNMT3B-transfested 293T
Validation: KO/KD, Orthogonal, Overexpression
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1.29 mg/mL
-
Buffer
- 1XPBS pH 7, 20 % Glycerol, 0.025 % ProClin 300
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- DNMT3B (DNA (Cytosine-5-)-Methyltransferase 3 beta (DNMT3B))
-
Alternative Name
- DNA methyltransferase 3 beta
-
Background
- DNA methyltransferase 3 beta , ICF , ICF1 , M.HsaIIIB,CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a DNA methyltransferase which is thought to function in de novo methylation, rather than maintenance methylation. The protein localizes primarily to the nucleus and its expression is developmentally regulated. Mutations in this gene cause the immunodeficiency-centromeric instability-facial anomalies (ICF) syndrome. Six alternatively spliced transcript variants have been described. The full length sequences of variants 4 and 5 have not been determined. [provided by RefSeq]
-
Molecular Weight
- 96 kDa
-
Gene ID
- 1789
-
UniProt
- Q9UBC3
Target
-